| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | Director | Common Stock | 74.1K | $1.89M | $25.56 | Jun 11, 2025 | Direct |
| AMEDISYS INC | Director | Common Stock | 0 | $898K | $91.51 | Aug 14, 2025 | Direct |
| Orthofix Medical Inc. | Director | Common Stock | 21.9K | $270K | $12.31 | Jun 18, 2025 | Direct |
| OTONOMY, INC. | Director | Common Stock | 3.4K | $299 | $0.09 | Nov 28, 2022 | Direct |
| OTONOMY, INC. | Director | Common Stock | 1.6K | $141 | $0.09 | Nov 28, 2022 | By Spouse |
| Orthofix Medical Inc. | Director | Employee Stock Option (Right to Buy) | 35.3K | Mar 11, 2025 | Direct | ||
| OTONOMY, INC. | Director | Stock Option (right to buy) | 27.5K | Jun 21, 2022 | Direct | ||
| Silverback Therapeutics, Inc. | Director | Stock Option (right to buy) | 18K | Jun 10, 2022 | Direct | ||
| Janux Therapeutics, Inc. | Director | Stock Option (right to buy) | 11.7K | Jun 11, 2025 | Direct | ||
| NUVASIVE INC | Director | RSUs | 4.82K | Jun 9, 2023 | Direct | ||
| NUVASIVE INC | Director | Common Stock, par value $0.001 per share | 0 | $42.67 | Sep 1, 2023 | Direct | |
| NUVASIVE INC | Director | Restricted Stock Unit | 0 | Sep 1, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AMED | AMEDISYS INC | Aug 14, 2025 | 1 | $0 | 4 | Aug 14, 2025 | Director |
| OFIX | Orthofix Medical Inc. | Jun 18, 2025 | 1 | $0 | 4 | Jun 23, 2025 | Director |
| JANX | Janux Therapeutics, Inc. | Jun 11, 2025 | 2 | $0 | 4 | Jun 13, 2025 | Director |
| AMED | AMEDISYS INC | May 3, 2025 | 1 | $0 | 4 | May 6, 2025 | Director |
| OFIX | Orthofix Medical Inc. | Mar 11, 2025 | 2 | $0 | 4 | Mar 13, 2025 | Director |
| OFIX | Orthofix Medical Inc. | Mar 11, 2025 | 0 | $0 | 3 | Mar 13, 2025 | Director |
| JANX | Janux Therapeutics, Inc. | Nov 5, 2024 | 1 | $0 | 4 | Nov 7, 2024 | Director |
| JANX | Janux Therapeutics, Inc. | Jun 26, 2024 | 2 | $0 | 4 | Jun 28, 2024 | Director |
| AMED | AMEDISYS INC | May 3, 2024 | 1 | $0 | 4 | May 7, 2024 | Director |
| JANX | Janux Therapeutics, Inc. | Feb 29, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Director |
| NUVA | NUVASIVE INC | Sep 1, 2023 | 11 | $0 | 4 | Sep 5, 2023 | Director |
| JANX | Janux Therapeutics, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| NUVA | NUVASIVE INC | Jun 9, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| AMED | AMEDISYS INC | May 3, 2023 | 1 | $0 | 4 | May 5, 2023 | Director |
| OTIC | OTONOMY, INC. | Nov 28, 2022 | 1 | -$4.34K | 4 | Nov 29, 2022 | Director |
| OTIC | OTONOMY, INC. | Jun 21, 2022 | 1 | $0 | 4 | Jun 23, 2022 | Director |
| JANX | Janux Therapeutics, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| SPRY | Silverback Therapeutics, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| AMED | AMEDISYS INC | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| NUVA | NUVASIVE INC | May 11, 2022 | 1 | $0 | 4 | May 13, 2022 | Director |
| OTIC | OTONOMY, INC. | Jun 22, 2021 | 1 | $0 | 4 | Jun 24, 2021 | Director |
| JANX | Janux Therapeutics, Inc. | Jun 10, 2021 | 0 | $0 | 3 | Jun 10, 2021 | Director |
| AMED | AMEDISYS INC | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| SPRY | Silverback Therapeutics, Inc. | Jun 4, 2021 | 1 | $0 | 4 | Sep 21, 2021 | Director |
| NUVA | NUVASIVE INC | May 18, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |